All In MedTech

Device Trial Radar · NCT03192696

Pantheris Atherectomy Treatment of In-Stent Restenosis In Lower Extremity Arteries

INSIGHT: EvaluatIoN of the PantheriS OCT- ImaGing AtHerectomy SysTem For Treatment of In-Stent Restenosis (ISR) Lesions In Lower Extremity Arteries

Last checked: Nov 19, 2026Latest source record: Mar 28, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

127

Actual

Start

Oct 19, 2017

Primary completion

Jun 1, 2021

Study completion Dec 1, 2021

Sponsor

Lead sponsor
Avinger, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jun 20, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A prospective, non-randomized, international, multi-center study to evaluate the safety and effectiveness of the Pantheris OCT-Imaging System to perform atherectomy in In-Stent Restenotic (ISR) lesions in lower extremity arteries.

Conditions

  • Peripheral Arterial Disease

Interventions

  • Atherectomy CatheterDevice

    Treatment of restenotic lesions within stents previously placed within the artery.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Freedom from a composite of major adverse events (MAEs) through 30-day follow-up (safety)Time frame: Day 0 through 30 days post treatment procedure
  2. Technical success of Pantheris catheter treatment (efficacy) deviceTime frame: Day 0

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • St. Bernards Medical Center

    Jonesboro, Arkansas

  • Arkansas Heart Hospital

    Little Rock, Arkansas

  • University of California San Diego (UCSD)

    San Diego, California

9 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.